Across TCGA pan-cancer cohorts, SLC25A29 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SLC25A29 data layer compared with 29 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher SLC25A29 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SLC25A29 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and HNSC show a favorable association.

CCRCC and HNSC are the cancer types where SLC25A29 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Tertile	All	1.000	0.377	.004	11	view →
HNSC	DFS	Median	III,IV	0.694	0.515	.031	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: SLC25A29 tumor-vs-normal RNA expression · all SLC25A29 data types